DEVICE: Provant Infinity (00868924000021)
Device Identifier (DI) Information
Provant Infinity
4210
Not in Commercial Distribution
Regenesis Biomedical, Inc.
4210
Not in Commercial Distribution
Regenesis Biomedical, Inc.
The device includes a Control Unit and Treatment Applicator. The Control Unit is enclosed in a UL-compliant injection-molded case made of medical grade polycarbonate. The device also includes a Treatment Applicator and an external power supply that are attached to the Control Unit. When not in use, the device is stored inside the carrying case. The device may be removed from the carrying case prior to administration of therapy. Provant Infinity is indicated for adjunctive use in the palliative treatment of postoperative pain and edema of soft tissue.
Device Characteristics
MR Unsafe | |
No | |
No | |
No | |
Yes | |
No | |
No | |
No | |
No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
---|---|---|---|---|
58761 | Deep-tissue electromagnetic stimulation system, home-use |
An assembly of devices designed to apply an electromagnetic (EM) field to body tissues to: 1) treat musculoskeletal disorders (e.g., osteoarthritis, osteoporosis); 2) treat body pain (musculoskeletal, postsurgical); and/or 3) help facilitate soft and hard tissue wound/injury healing, with no production of a therapeutic deep heat. It includes an electrically-powered control unit, application pads/flat coils intended to emit EM radiation to the treatment site (e.g., joint), and carrying case for portability. It is not intended to apply an electric current directly to the body. The system is intended to be used in clinical and home settings.
|
Active | false |
FDA Product Code
[?]Product Code | Product Code Name |
---|---|
ILX | Diathermy, Shortwave, For Use Other Than Applying Therapeutic Deep Heat |
FDA Premarket Submission
FDA Premarket Submission Number [?] | Supplement Number [?] |
---|---|
K131979 | 000 |
Sterilization
Storage and Handling
[?]Storage and Handling |
---|
Handling Environment Temperature: between 12 and 32 Degrees Celsius |
Handling Environment Humidity: between 15 and 90 Percent (%) Relative Humidity |
Storage Environment Temperature: between 20 and 50 Degrees Celsius |
Handling Environment Atmospheric Pressure: between 700 and 1060 millibar |
Clinically Relevant Size
[?]Size Type Text |
---|
No Device Sizes |
Device Record Status
2af93b37-2a81-4e78-9208-4fdb1bf7870e
June 27, 2025
2
January 21, 2021
June 27, 2025
2
January 21, 2021
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
---|---|---|---|---|---|
No Package DIs found |
Secondary DI
[?]Issuing Agency [?] | Secondary DI Number |
---|---|
No Secondary DIs found |
Unit of Use DI
[?]
Unit of Use DI Number:
No Unit of Use DI Numbers Found
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
480-297-5800
Randy.Chavez@regenesisbio.com
Randy.Chavez@regenesisbio.com